Elicio Therapeutics Inc (ELTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,571 | -51,898 | -35,195 | -28,208 | -54,573 |
| Depreciation Amortization | 1,345 | 1,253 | 1,170 | 1,057 | 2,685 |
| Accounts receivable | N/A | N/A | N/A | N/A | -806 |
| Accounts payable and accrued liabilities | -366 | -3,331 | 23 | 1,125 | -866 |
| Other Working Capital | -3,445 | 3,959 | -57 | -150 | -25,970 |
| Other Operating Activity | 5,085 | 12,949 | 1,365 | 3,997 | 26,887 |
| Operating Cash Flow | $-36,952 | $-37,068 | $-32,694 | $-22,179 | $-52,643 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -84 | -32 | -654 | -382 |
| Investing Cash Flow | $-16 | $-84 | $-32 | $-654 | $-382 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 9,866 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 19,727 | 10,000 | N/A | 302 |
| Debt Repayment | N/A | N/A | N/A | N/A | -9 |
| Common Stock Issued | 26,829 | 23,143 | 7,126 | 82 | 109,346 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -10 |
| Other Financing Activity | 0 | -549 | 21,487 | 21,120 | -2,458 |
| Financing Cash Flow | $36,695 | $42,321 | $38,613 | $21,202 | $107,171 |
| Exchange Rate Effect | 48 | 22 | N/A | N/A | 3 |
| Beginning Cash Position | 19,492 | 14,301 | 8,414 | 10,045 | 34,607 |
| End Cash Position | 19,267 | 19,492 | 14,301 | 8,414 | 88,756 |
| Net Cash Flow | $-225 | $5,191 | $5,887 | $-1,631 | $54,149 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,952 | -37,068 | -32,694 | -22,179 | -52,643 |
| Capital Expenditure | -16 | -87 | -66 | -654 | -382 |
| Free Cash Flow | -36,968 | -37,155 | -32,760 | -22,833 | -53,025 |